HB 4070 proposes to regulate the sale, design, and manufacture of orthodontic devices in Texas by requiring in-person examinations, diagnostic imaging, and formal prescriptions from licensed dentists before such devices can be sold or manufactured for a patient. The stated intent of the bill is to protect patients from risks associated with receiving orthodontic treatment without professional evaluation, especially in cases where underlying conditions like gum disease or structural issues may contraindicate the use of certain devices.
However, the bill represents a clear expansion in the scope of state government regulation. By introducing new statutory requirements and enforcement mechanisms, it increases the authority of the Texas State Board of Dental Examiners without evidence of systemic failure or significant harm in current practices. While the fiscal note indicates that these changes would not require new taxpayer expenditures and could be managed with existing agency resources, the burden of compliance is shifted to private dental professionals and businesses, particularly those operating in emerging models like direct-to-consumer orthodontics or telehealth.
This expanded regulatory regime imposes substantial new obligations on individuals and businesses. It includes mandatory exams and documentation, seven-year record retention, and detailed restrictions on who can sell or provide orthodontic-related services. These requirements limit market access, reduce patient choice, and disproportionately affect newer, more affordable care models. As a result, the legislation places a significant compliance and operational burden on providers without demonstrating a proportionate public safety benefit.
In summary, while HB 4070 aims to safeguard patient health, it does so by growing the regulatory footprint of government, limiting free enterprise, and reducing individual autonomy in healthcare decisions. These impacts conflict with the principles of limited government, personal responsibility, and open markets. Accordingly, Texas Policy Research recommends that lawmakers vote NO on HB 4070.
- Individual Liberty: The bill restricts individuals' freedom to choose how and from whom they receive orthodontic care. By requiring an in-person dental examination and diagnostics before purchasing or using an orthodontic device, the bill effectively eliminates access to direct-to-consumer and telehealth-based services, even if the patient is informed and willing to assume the risk. This intrusion substitutes state mandates for personal medical decision-making and limits autonomy in seeking cost-effective care.
- Personal Responsibility: The bill removes the opportunity for individuals to take personal responsibility for their own dental choices. Rather than empowering patients to consult, consent, and weigh their treatment options based on risk, the bill mandates a one-size-fits-all process that presumes people cannot responsibly assess or select orthodontic services without direct state involvement through licensed dentists.
- Free Enterprise: The bill imposes a significant barrier to market entry for companies offering innovative orthodontic services, particularly those relying on virtual care models or mail-order aligners. By limiting the sale and customization of orthodontic devices to dentists or those with explicit dentist confirmation, the bill protects legacy dental practices from competition and undermines innovation. This directly contradicts the free market principle of open competition and consumer-driven choice.
- Private Property Rights: While the bill does not directly alter property rights, it could affect businesses’ ability to operate freely and use their property (including technology platforms, design tools, and equipment) in lawful commerce. Businesses that develop or sell orthodontic devices without an on-site dental office or affiliated practitioner may find their operations curtailed under the new regulatory restrictions.
- Limited Government: The bill expands the regulatory scope of the state by adding new duties, compliance requirements, and documentation mandates for private actors. Even though it does not increase state spending, it increases the power of government to control routine commercial and healthcare interactions. This move toward top-down regulation, without a clear and proportional threat to public health, violates the principle that government should be limited to essential functions and not interfere in voluntary transactions.